Evidence map›Paper›PMID 40808351›Full record

ArticleOncology reports2025

[Retracted] Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer.

Yi Lei, Wang Guo, Bowang Chen, Lu Chen, Jiaxin Gong, Weimin Li

Abstract readRetraction Notice
In one paragraph

Article in Oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Yi LeiInternational Medical Center/Department of General Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Wang GuoInternational Medical Center/Department of General Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Bowang ChenInternational Medical Center/Department of General Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Lu ChenInternational Medical Center/Department of General Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Jiaxin GongInternational Medical Center/Department of General Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Weimin LiDepartment of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that certain of the TEM microscopic data featured in Fig. 3C on p. 3443, the RIP assay data in Fig. 4A and the western blot data in Fig. 4D on p. 3444 were strikingly similar to data that had appeared in other articles written by different authors at different research institutes, which had either already been published before this article was received at

Indexed as

exosomegefitinib resistanceH19non‑small cell lung cancer

Identifiers

PMID40808351
PMCPMC12373362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.